IMARC Group’s latest research indicates that the oxygen therapy market was valued at USD 21.4 billion in 2025 and is projected to reach USD 35.4 billion by 2034, expanding at a CAGR of 5.58% during 2026-2034. That is roughly USD 14 billion of added value, as chronic respiratory conditions, ageing populations and the shift to home-based care raise demand for oxygen equipment and delivery...